vs
Side-by-side financial comparison of Nextpower Inc. (NXT) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $909.4M, roughly 1.2× Nextpower Inc.). Nextpower Inc. runs the higher net margin — 14.4% vs -127.8%, a 142.2% gap on every dollar of revenue. On growth, Nextpower Inc. posted the faster year-over-year revenue change (33.9% vs -2.5%). PERRIGO Co plc produced more free cash flow last quarter ($148.6M vs $118.5M). Over the past eight quarters, Nextpower Inc.'s revenue compounded faster (11.1% CAGR vs 1.3%).
Nextpower Inc. (NXT) is a global energy technology provider based in Fremont, California.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
NXT vs PRGO — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $909.4M | $1.1B |
| Net Profit | $131.2M | $-1.4B |
| Gross Margin | 31.7% | 32.6% |
| Operating Margin | 19.4% | -116.0% |
| Net Margin | 14.4% | -127.8% |
| Revenue YoY | 33.9% | -2.5% |
| Net Profit YoY | 13.8% | -3093.9% |
| EPS (diluted) | $0.85 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $909.4M | $1.1B | ||
| Q3 25 | $905.3M | $1.0B | ||
| Q2 25 | $864.3M | $1.1B | ||
| Q1 25 | $924.3M | $1.0B | ||
| Q4 24 | $679.4M | $1.1B | ||
| Q3 24 | $635.6M | $1.1B | ||
| Q2 24 | $719.9M | $1.1B | ||
| Q1 24 | $736.5M | $1.1B |
| Q4 25 | $131.2M | $-1.4B | ||
| Q3 25 | $146.9M | $7.5M | ||
| Q2 25 | $157.2M | $-8.4M | ||
| Q1 25 | $156.8M | $-6.4M | ||
| Q4 24 | $115.3M | $-44.4M | ||
| Q3 24 | $115.4M | $-21.0M | ||
| Q2 24 | $121.7M | $-108.4M | ||
| Q1 24 | $205.2M | $2.0M |
| Q4 25 | 31.7% | 32.6% | ||
| Q3 25 | 32.4% | 36.1% | ||
| Q2 25 | 32.6% | 34.4% | ||
| Q1 25 | 33.1% | 37.6% | ||
| Q4 24 | 35.5% | 33.9% | ||
| Q3 24 | 35.4% | 37.2% | ||
| Q2 24 | 33.0% | 37.0% | ||
| Q1 24 | 46.2% | 33.1% |
| Q4 25 | 19.4% | -116.0% | ||
| Q3 25 | 20.0% | 7.0% | ||
| Q2 25 | 21.5% | 4.3% | ||
| Q1 25 | 21.1% | 4.5% | ||
| Q4 24 | 22.1% | 10.0% | ||
| Q3 24 | 21.0% | 7.4% | ||
| Q2 24 | 22.2% | -2.5% | ||
| Q1 24 | 36.8% | -5.1% |
| Q4 25 | 14.4% | -127.8% | ||
| Q3 25 | 16.2% | 0.7% | ||
| Q2 25 | 18.2% | -0.8% | ||
| Q1 25 | 17.0% | -0.6% | ||
| Q4 24 | 17.0% | -3.9% | ||
| Q3 24 | 18.2% | -1.9% | ||
| Q2 24 | 16.9% | -10.2% | ||
| Q1 24 | 27.9% | 0.2% |
| Q4 25 | $0.85 | $-10.23 | ||
| Q3 25 | $0.97 | $0.05 | ||
| Q2 25 | $1.04 | $-0.06 | ||
| Q1 25 | $1.05 | $-0.05 | ||
| Q4 24 | $0.79 | $-0.32 | ||
| Q3 24 | $0.79 | $-0.15 | ||
| Q2 24 | $0.84 | $-0.79 | ||
| Q1 24 | $1.52 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $952.6M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.2B | $2.9B |
| Total Assets | $3.8B | $8.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $952.6M | — | ||
| Q3 25 | $845.3M | $432.1M | ||
| Q2 25 | $743.4M | $454.2M | ||
| Q1 25 | $766.1M | $409.9M | ||
| Q4 24 | $693.5M | $558.8M | ||
| Q3 24 | $561.9M | $1.5B | ||
| Q2 24 | $471.9M | $542.8M | ||
| Q1 24 | $474.1M | $658.5M |
| Q4 25 | $2.2B | $2.9B | ||
| Q3 25 | $2.0B | $4.4B | ||
| Q2 25 | $1.8B | $4.5B | ||
| Q1 25 | $1.6B | $4.4B | ||
| Q4 24 | $1.4B | $4.3B | ||
| Q3 24 | $1.3B | $4.6B | ||
| Q2 24 | $1.1B | $4.5B | ||
| Q1 24 | $961.0M | $4.7B |
| Q4 25 | $3.8B | $8.5B | ||
| Q3 25 | $3.7B | $10.1B | ||
| Q2 25 | $3.4B | $10.1B | ||
| Q1 25 | $3.2B | $9.8B | ||
| Q4 24 | $3.0B | $9.6B | ||
| Q3 24 | $2.8B | $11.2B | ||
| Q2 24 | $2.6B | $10.4B | ||
| Q1 24 | $2.5B | $10.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $123.3M | $175.4M |
| Free Cash FlowOCF − Capex | $118.5M | $148.6M |
| FCF MarginFCF / Revenue | 13.0% | 13.4% |
| Capex IntensityCapex / Revenue | 0.5% | 2.4% |
| Cash ConversionOCF / Net Profit | 0.94× | — |
| TTM Free Cash FlowTrailing 4 quarters | $587.3M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.3M | $175.4M | ||
| Q3 25 | $186.9M | $51.7M | ||
| Q2 25 | $81.3M | $75.9M | ||
| Q1 25 | $237.3M | $-64.5M | ||
| Q4 24 | $143.8M | $312.6M | ||
| Q3 24 | $153.8M | $42.2M | ||
| Q2 24 | $120.8M | $9.5M | ||
| Q1 24 | $111.5M | $-1.4M |
| Q4 25 | $118.5M | $148.6M | ||
| Q3 25 | $171.4M | $29.8M | ||
| Q2 25 | $70.1M | $56.7M | ||
| Q1 25 | $227.2M | $-90.0M | ||
| Q4 24 | $134.9M | $274.9M | ||
| Q3 24 | $141.8M | $15.1M | ||
| Q2 24 | $118.0M | $-18.9M | ||
| Q1 24 | $109.2M | $-26.5M |
| Q4 25 | 13.0% | 13.4% | ||
| Q3 25 | 18.9% | 2.9% | ||
| Q2 25 | 8.1% | 5.4% | ||
| Q1 25 | 24.6% | -8.6% | ||
| Q4 24 | 19.9% | 24.2% | ||
| Q3 24 | 22.3% | 1.4% | ||
| Q2 24 | 16.4% | -1.8% | ||
| Q1 24 | 14.8% | -2.4% |
| Q4 25 | 0.5% | 2.4% | ||
| Q3 25 | 1.7% | 2.1% | ||
| Q2 25 | 1.3% | 1.8% | ||
| Q1 25 | 1.1% | 2.4% | ||
| Q4 24 | 1.3% | 3.3% | ||
| Q3 24 | 1.9% | 2.5% | ||
| Q2 24 | 0.4% | 2.7% | ||
| Q1 24 | 0.3% | 2.3% |
| Q4 25 | 0.94× | — | ||
| Q3 25 | 1.27× | 6.89× | ||
| Q2 25 | 0.52× | — | ||
| Q1 25 | 1.51× | — | ||
| Q4 24 | 1.25× | — | ||
| Q3 24 | 1.33× | — | ||
| Q2 24 | 0.99× | — | ||
| Q1 24 | 0.54× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NXT
| Transferred Over Time | $763.9M | 84% |
| Transferred At Point In Time | $145.4M | 16% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |